Lv11
20 积分 2025-03-18 加入
Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study
5小时前
已完结
A Mixed Methods Study of Anxiety and Patient Perception of Safety in Contrast‐Enhanced MRI
1个月前
已完结
Diagnostic Accuracy of FEF25-75 for Bronchial Hyperresponsiveness in Patients with Suspected Asthma and/or Allergic Rhinitis: A Systematic Review and Meta-analysis
4个月前
已完结
Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study
5个月前
已完结
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
5个月前
已完结
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
5个月前
已完结
First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
8个月前
已完结
Individual patient data meta-analysis of randomized controlled trials of first-line tyrosine kinase inhibitors in patients with EGFR mutation-positive non-small cell lung cancer
10个月前
已关闭
Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer
10个月前
已完结
Delayed or upfront brain radiotherapy in treatment-naïve lung cancer patients with asymptomatic or minimally symptomatic brain metastases and ALK rearrangements (DURABLE)
10个月前
已关闭
皖公网安备34019202002308
